
NHSA welcomes multimillion pound clinical trials investment
New investment in UK clinical research welcomed by NHSA Chief Executive
2nd September 2024
Following the government’s announcement of a joint public-private investment programme worth up to £400million to strengthen clinical trials and improve medicines manufacturing in the UK, the NHSA’s Chief Executive, Hannah Davies, has welcomed the ‘much-needed’ investment.
Hannah said: “We are delighted to see the importance of health research recognised with this much-needed investment, which will not only help to improve patient care and health outcomes but also bring economic benefits to the UK health and life sciences sector.
“Our analysis of health research spending exposed the persisting regional imbalance in health research funding, with the North losing out on millions of pounds compared to the Greater South East. We hope that this new investment will be spread fairly across the UK so the North’s health research excellence, and proven capabilities in delivering clinical trials, have the opportunity to thrive and compete on a global scale.”
Related News Articles
GALLERY: Labour Party Conference 2025
View our gallery and round up of events at the Labour Party Conference
Read the articleNHSA's Ageing North group celebrates national UN Day of Older Persons
A national day which examines the part older people play in society, follows a roundtable around ageing and productivity at the Labour Party Conference
Read the articlePoor diets in the North go hand-in-hand with the highest rates of cancer, diabetes, heart disease and food insecurity in the country
Northern regions have some of the poorest diets in England, putting them at risk of conditions such as obesity, hypertension and other preventable diseases.
Read the article